| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |






From the Departments of Pathology and Laboratory
Medicine,*
Urology,
and
Biochemistry,
Emory University School
of Medicine, Atlanta; and the Atlanta VA Medical
Center,
Decatur, Georgia
The expression patterns of 7075 genes were analyzed in four conventional (clear cell) renal cell carcinomas (RCC), one chromophobe RCC, and two oncocytomas using cDNA microarrays. Expression profiles were compared among tumors using various clustering algorithms, thereby separating the tumors into two categories consistent with corresponding histopathological diagnoses. Specifically, conventional RCCs were distinguished from chromophobe RCC/oncocytomas based on large-scale gene expression patterns. Chromophobe RCC/oncocytomas displayed similar expression profiles, including genes involved with oxidative phosphorylation and genes expressed normally by distal nephron, consistent with the mitochondrion-rich morphology of these tumors and the theory that both lesions are related histogenetically to distal nephron epithelium. Conventional RCCs underexpressed mitochondrial and distal nephron genes, and were further distinguished from chromophobe RCC/oncocytomas by overexpression of vimentin and class II major histocompatibility complex-related molecules. Novel, tumor-specific expression of four genesvimentin, class II major histocompatibility complex-associated invariant chain (CD74), parvalbumin, and galectin-3was confirmed in an independent tumor series by immunohistochemistry. Vimentin was a sensitive, specific marker for conventional RCCs, and parvalbumin was detected primarily in chromophobe RCC/oncocytomas. In conclusion, histopathological subtypes of renal epithelial neoplasia were characterized by distinct patterns of gene expression. Expression patterns were useful for identifying novel molecular markers with potential diagnostic utility.
This article has been cited by other articles:
![]() |
M. Brunelli, B. Delahunt, S. Gobbo, R. Tardanico, A. Eccher, S. Bersani, P. Cossu-Rocca, C. Parolini, P. Balzarini, F. Menestrina, et al. Diagnostic Usefulness of Fluorescent Cytogenetics in Differentiating Chromophobe Renal Cell Carcinoma From Renal Oncocytoma: A Validation Study Combining Metaphase and Interphase Analyses Am J Clin Pathol, January 1, 2010; 133(1): 116 - 126. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lichtenfels, S. P. Dressler, M. Zobawa, C. V. Recktenwald, A. Ackermann, D. Atkins, M. Kersten, A. Hesse, M. Puttkammer, F. Lottspeich, et al. Systematic Comparative Protein Expression Profiling of Clear Cell Renal Cell Carcinoma: A PILOT STUDY BASED ON THE SEPARATION OF TISSUE SPECIMENS BY TWO-DIMENSIONAL GEL ELECTROPHORESIS Mol. Cell. Proteomics, December 1, 2009; 8(12): 2827 - 2842. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. S. Morris and A. I. McClatchey Aberrant epithelial morphology and persistent epidermal growth factor receptor signaling in a mouse model of renal carcinoma PNAS, June 16, 2009; 106(24): 9767 - 9772. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Hegedus, C. F. Skibola, M. Warner, D. R. Skibola, D. Alexander, S. Lim, N. L. Dangleben, L. Zhang, M. Clark, R. M. Pfeiffer, et al. Decreased Urinary Beta-Defensin-1 Expression as a Biomarker of Response to Arsenic Toxicol. Sci., November 1, 2008; 106(1): 74 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Liu, C.-Y. Lin, W.-C. Lin, S.-W. Tang, M.-K. Lai, and J.-Y. Lin Up-Regulation of Vascular Endothelial Growth Factor-D Expression in Clear Cell Renal Cell Carcinoma by CD74: A Critical Role in Cancer Cell Tumorigenesis J. Immunol., November 1, 2008; 181(9): 6584 - 6594. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Gore, D. Starlets, N. Maharshak, S. Becker-Herman, U. Kaneyuki, L. Leng, R. Bucala, and I. Shachar Macrophage Migration Inhibitory Factor Induces B Cell Survival by Activation of a CD74-CD44 Receptor Complex J. Biol. Chem., February 1, 2008; 283(5): 2784 - 2792. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rohan, J. J. Tu, J. Kao, P. Mukherjee, F. Campagne, X. K. Zhou, E. Hyjek, M. A. Alonso, and Y.-T. Chen Gene Expression Profiling Separates Chromophobe Renal Cell Carcinoma from Oncocytoma and Identifies Vesicular Transport and Cell Junction Proteins as Differentially Expressed Genes Clin. Cancer Res., December 1, 2006; 12(23): 6937 - 6945. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hotakainen, S. Lintula, B. Ljungberg, P. Finne, A. Paju, U.-H. Stenman, and J. Stenman Expression Of Human Chorionic Gonadotropin {beta}-Subunit Type I Genes Predicts Adverse Outcome In Renal Cell Carcinoma J. Mol. Diagn., November 1, 2006; 8(5): 598 - 603. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Starlets, Y. Gore, I. Binsky, M. Haran, N. Harpaz, L. Shvidel, S. Becker-Herman, A. Berrebi, and I. Shachar Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival Blood, June 15, 2006; 107(12): 4807 - 4816. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Raman, N. P. Mongan, L. Liu, S. K. Tickoo, D. M. Nanus, D. S. Scherr, and L. J. Gudas Decreased expression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma Carcinogenesis, March 1, 2006; 27(3): 499 - 507. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-T. Chen, J. J. Tu, J. Kao, X. K. Zhou, and M. Mazumdar Messenger RNA Expression Ratios among Four Genes Predict Subtypes of Renal Cell Carcinoma and Distinguish Oncocytoma from Carcinoma Clin. Cancer Res., September 15, 2005; 11(18): 6558 - 6566. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. J. Yang, M.-H. Tan, H. L. Kim, J. A. Ditlev, M. W. Betten, C. E. Png, E. J. Kort, K. Futami, K. A. Furge, M. Takahashi, et al. A Molecular Classification of Papillary Renal Cell Carcinoma Cancer Res., July 1, 2005; 65(13): 5628 - 5637. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Togashi, T. Katagiri, S. Ashida, T. Fujioka, O. Maruyama, Y. Wakumoto, Y. Sakamoto, M. Fujime, Y. Kawachi, T. Shuin, et al. Hypoxia-Inducible Protein 2 (HIG2), a Novel Diagnostic Marker for Renal Cell Carcinoma and Potential Target for Molecular Therapy Cancer Res., June 1, 2005; 65(11): 4817 - 4826. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Schuetz, Q. Yin-Goen, M. B. Amin, C. S. Moreno, C. Cohen, C. D. Hornsby, W. L. Yang, J. A. Petros, M. M. Issa, J. G. Pattaras, et al. Molecular Classification of Renal Tumors by Gene Expression Profiling J. Mol. Diagn., May 1, 2005; 7(2): 206 - 218. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Wang, R. Lichtenfels, J. Bukur, Y. Ngalame, M. C. Panelli, B. Seliger, and F. M. Marincola Ontogeny and Oncogenesis Balance the Transcriptional Profile of Renal Cell Cancer Cancer Res., October 15, 2004; 64(20): 7279 - 7287. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-H. Tan, C. G. Rogers, J. T. Cooper, J. A. Ditlev, T. J. Maatman, X. Yang, K. A. Furge, and B. T. Teh Gene Expression Profiling of Renal Cell Carcinoma Clin. Cancer Res., September 15, 2004; 10(18): 6315S - 6321S. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Stadler Therapeutic Options for Variant Renal Cancer: A True Orphan Disease Clin. Cancer Res., September 15, 2004; 10(18): 6393S - 6396S. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Scherzer, K. Offe, M. Gearing, H. D. Rees, G. Fang, C. J. Heilman, C. Schaller, H. Bujo, A. I. Levey, and J. J. Lah Loss of Apolipoprotein E Receptor LR11 in Alzheimer Disease Arch Neurol, August 1, 2004; 61(8): 1200 - 1205. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Struckmann, P. Schraml, R. Simon, K. Elmenhorst, M. Mirlacher, J. Kononen, and H. Moch Impaired Expression of the Cell Cycle Regulator BTG2 Is Common in Clear Cell Renal Cell Carcinoma Cancer Res., March 1, 2004; 64(5): 1632 - 1638. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Li, M. Cuilleron, A. Gentil-Perret, M. Cottier, K. Passebosc-Faure, C. Lambert, C. Genin, and J. Tostain Rapid and Sensitive Detection of Messenger RNA Expression for Molecular Differential Diagnosis of Renal Cell Carcinoma Clin. Cancer Res., December 15, 2003; 9(17): 6441 - 6446. [Abstract] [Full Text] [PDF] |
||||
![]() |
S D Jenson, R S Robetorye, S D Bohling, J A Schumacher, J W Morgan, M S Lim, and K S J Elenitoba-Johnson Validation of cDNA microarray gene expression data obtained from linearly amplified RNA Mol. Pathol., December 1, 2003; 56(6): 307 - 312. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C. Twine, J. A. Stover, B. Marshall, G. Dukart, M. Hidalgo, W. Stadler, T. Logan, J. Dutcher, G. Hudes, A. J. Dorner, et al. Disease-associated Expression Profiles in Peripheral Blood Mononuclear Cells from Patients with Advanced Renal Cell Carcinoma Cancer Res., September 15, 2003; 63(18): 6069 - 6075. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang, I. H. Diab, and Z. E. Zehner ZBP-89 represses vimentin gene transcription by interacting with the transcriptional activator, Sp1 Nucleic Acids Res., June 1, 2003; 31(11): 2900 - 2914. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P.T. Higgins, R. Shinghal, H. Gill, J. H. Reese, M. Terris, R. J. Cohen, M. Fero, J. R. Pollack, M. van de Rijn, and J. D. Brooks Gene Expression Patterns in Renal Cell Carcinoma Assessed by Complementary DNA Microarray Am. J. Pathol., March 1, 2003; 162(3): 925 - 932. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Ibrahim, Y. Allory, F. Commo, B. Gattegno, P. Callard, and P. Paul Altered Pattern of Major Histocompatibility Complex Expression in Renal Carcinoma: Tumor-Specific Expression of the Nonclassical Human Leukocyte Antigen-G Molecule Is Restricted to Clear Cell Carcinoma While Up-Regulation of Other Major Histocompatibility Complex Antigens Is Primarily Distributed in All Subtypes of Renal Carcinoma Am. J. Pathol., February 1, 2003; 162(2): 501 - 508. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Giordano, D. G. Thomas, R. Kuick, M. Lizyness, D. E. Misek, A. L. Smith, D. Sanders, R. T. Aljundi, P. G. Gauger, N. W. Thompson, et al. Distinct Transcriptional Profiles of Adrenocortical Tumors Uncovered by DNA Microarray Analysis Am. J. Pathol., February 1, 2003; 162(2): 521 - 531. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Weinschenk, C. Gouttefangeas, M. Schirle, F. Obermayr, S. Walter, O. Schoor, R. Kurek, W. Loeser, K.-H. Bichler, D. Wernet, et al. Integrated Functional Genomics Approach for the Design of Patient-individual Antitumor Vaccines Cancer Res., October 15, 2002; 62(20): 5818 - 5827. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Robetorye, S. D. Bohling, J. W. Morgan, G. C. Fillmore, M. S. Lim, and K. S. J. Elenitoba-Johnson Microarray Analysis of B-Cell Lymphoma Cell Lines with the t(14;18) J. Mol. Diagn., August 1, 2002; 4(3): 123 - 136. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Kirschmann, E. A. Seftor, S. F. T. Fong, D. R. C. Nieva, C. M. Sullivan, E. M. Edwards, P. Sommer, K. Csiszar, and M. J. C. Hendrix A Molecular Role for Lysyl Oxidase in Breast Cancer Invasion Cancer Res., August 1, 2002; 62(15): 4478 - 4483. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Gewirtz, L. S. Collier-Hyams, A. N. Young, T. Kucharzik, W. J. Guilford, J. F. Parkinson, I. R. Williams, A. S. Neish, and J. L. Madara Lipoxin A4 Analogs Attenuate Induction of Intestinal Epithelial Proinflammatory Gene Expression and Reduce the Severity of Dextran Sodium Sulfate-Induced Colitis J. Immunol., May 15, 2002; 168(10): 5260 - 5267. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Simonnet, N. Alazard, K. Pfeiffer, C. Gallou, C. Beroud, J. Demont, R. Bouvier, H. Schagger, and C. Godinot Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma Carcinogenesis, May 1, 2002; 23(5): 759 - 768. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |